BioBuzz - Greater Philadelphia

Geography matters. Community matters. ?????? matter. Community is at the heart of everything that we do at BioBuzz. ?? Which is why we’re thrilled to showcase the community that continues to drive us to do what we do ???????? ?????? ?????????? ?????? with the launch of our Weekly Takeovers in Philly this September. Every week a new ambassador, community member, or ecosystem friend, will “takeover” our Greater Philadelphia showcase page. ?? They'll "own" the page for the week as they buzz about themselves, the incredible people around them, the work they’re doing and supporting, and the things that they’re passionate about. ??????????????? So are we. ????????????????????? Sign up today: https://lnkd.in/eiRdEKdc ???????? ?????????????? ????????'?? ???? ?? ???????? ??????? TAG them below. ???????????? ???????? ???????? ???? ???????????? ?????????????? ???????? ?????? ???????? ???? ???????? ???????????? ?????? ???????????? ?????? ?????? ???????????? ???? ?????????????? ?????? ???????? ????????????????. ??????????????????? Message Cat, Annabel, Bryan or Joshua. #lifesciences #biotech #pharma #CGT #philly #community #biobuzz

?? New Report: Penn's Economic Powerhouse in Philly & Beyond The University of Pennsylvania isn’t just a world-class institution—it’s an economic engine for Philadelphia and the broader region. According to Penn’s FY24 Economic Impact Report, the University and Health System generated $37.7 billion in annual economic activity, supporting one in seven jobs in Philadelphia. Major takeaways: ? Job Creation – 106,600 jobs in Philly alone, with 53,000 directly employed by Penn. ? Construction & Infrastructure – $1B invested in capital projects, creating 6,900 jobs. ? Research & Innovation – $1.37B in R&D spending, fueling billions in economic output. ? Local Business Support – $572M spent with 5,000+ local businesses, including $170M with women- and minority-owned enterprises. ? Tourism & Student Spending – $402M in economic activity from students and visitors. Penn’s influence extends far beyond campus walls. From groundbreaking research to community investment, its footprint is shaping the future of Philadelphia’s economy. Source: https://lnkd.in/eiYip3iw

?? A few tickets left! Don’t miss our next event Philadelphia’s Push: Breaking Barriers in Rare Disease Research Following the incredible energy from our BioInnovation Series launch last month, we’re keeping the momentum going with Stop #2—a deep dive into the breakthroughs and challenges in rare disease research. Co-hosted with uCity Square and Wexford Science & Technology, LLC, this science-focused event is free for all except vendors and service providers. With 150+ attendees expected, it's a must-attend for the life sciences community. ?? Tuesday, March 18, 2025 ?? 4PM – 7PM ?? Quorum at University City Science Center Hear from industry leaders: ?? Monique Molloy, Chief Administrative Officer, GEMMA Biotherapeutics ?? Mary Zuccato, COO, Every Cure ?? Robert Long, Executive Director, Uplifting Athletes ?? Cait Butrica, CFRE , Director of Development, Life Science Cares Philadelphia Lastly, a big thank you to our BioInnovation Series sponsors for making this series possible! ?? CRB // Brandywine Realty Trust // B?labs // WuXi Advanced Therapies // Keen Compressed Gas Co. // Choice MedWaste // Kymanox // Biocair // Conner Strong & Buckelew // QIAGEN // Workforce Genetics // uCity Square // Wexford Science & Technology, LLC // BioBuzz Interested or have questions? Reach out to [email protected]. Secure your spot before it’s too late—see you there!?

Look at how our neighbor, New Jersey, is supporting life science companies and helping them stay and grow. On March 12, 2025, the New Jersey Economic Development Authority (NJEDA) approved $5.24 million in tax credits through the Emerge Program to assist SUN PHARMA in relocating its U.S. headquarters to Princeton. This strategic investment underscores New Jersey’s dedication to fostering growth in the life sciences sector and creating an environment where companies can thrive. It’s a great example of how proactive state incentives can drive innovation and economic development in the biotech and pharmaceutical industries.

?? Event alert from Wharton Biotech Conference organized by Penn Biotech Group

??Biotech Milestone: Third Arc Bio Doses First Patient in ARC101 Trial Spring House,PA- Based Third Arc Bio has officially entered the clinic. The company just announced that the first patient has been dosed in its Phase 1 trial of ARC101, a T cell engager targeting Claudin 6 (CLDN6) for patients with advanced solid tumors. This first-in-human study will evaluate dosing, safety, pharmacokinetics, and preliminary efficacy—a critical step for ARC101, which is designed to achieve high specificity for CLDN6, potentially offering a superior therapeutic index compared to other approaches. "ARC101 is the first program from our growing pipeline to reach the clinic – signifying Third Arc Bio's transition into a clinical stage company," said?Peter Lebowitz, MD, PhD, Chief Executive Officer and Chief Medical Officer of Third Arc Bio. "Given ARC101's remarkable specificity for CLDN6 over other Claudin proteins, we believe ARC101 has the potential to achieve a superior therapeutic index in the clinic. As we advance the ARC101 clinical program, we are also rapidly progressing our next programs towards the clinic with the execution of critical IND-enabling studies." With this milestone, Third Arc Bio transitions into a clinical-stage biotech while continuing to advance additional pipeline programs built on its Synergy Platform for solid tumors and Tethering Platform for immunology & inflammation. The company plans to present preclinical data on ARC101 at the upcoming 2025 AACR Annual Meeting. Press release: https://lnkd.in/eERrBzCh

?? Breaking News: CHOP Receives Largest Gift in History to Build Roberts Children’s Health Children's Hospital of Philadelphia (CHOP) just announced the largest single donation in its 170-year history—$125 million from Aileen and Brian Roberts and their family—to help build Roberts Children’s Health, a groundbreaking inpatient tower and revitalized hospital campus. Set to open in 2028, the 20+ story facility will redefine pediatric care, bringing together cutting-edge diagnostics, fully private patient rooms, and comprehensive family support services. “At CHOP, we’re focused on finding answers to the toughest medical challenges so that every child has the chance for a healthier future," said CHOP President & CEO Madeline Bell. "Roberts Children’s Health will greatly enhance the hospital experience for our patients and their families, equip our staff with the latest innovations, and revolutionize how we provide care.” This historic gift builds on the Roberts family's long-standing support for CHOP, including their role in launching the Roberts Center for Pediatric Research and the Roberts Collaborative for Genetics and Individualized Medicine. As Brian and Aileen Roberts put it: "CHOP is already the world’s leading children’s hospital, where the best doctors, technology, and patient care come together to serve families. We’re honored and humbled to help ensure CHOP remains a magnet for the greatest medical talent, a refuge for those facing the most complex cases, and a beacon of hope for decades to come.” Huge congratulations to the CHOP team on this transformative milestone! Full Press Release: https://lnkd.in/eeKTNitb

Keystone LifeSci Collaborative keep up the great work – the important work you're doing is truly impactful! Check out a recap of their latest Quarterly Meeting ??

??BioLabs Philadelphia is excited to announce they've extended the deadline for Investor Day to FRIDAY at midnight! APPLY NOW AND SPREAD THE WORD: https://lnkd.in/ekhwc3KH

Start your morning off right.